7.971.24% ( -0.10 )
Delay Closed: Nov 13, 15:00:00Valuation
Current ValuationThe current P/E ratio is 23.68, above the reasonable range, cheaper than 11.74% of the time in the past 5 years, and the industry ranks 60/222, the industry Median 22.14.
23.68xP/E
¥7.97Stock price
¥0.34Earnings per share
23.68xP/E
Stock price¥7.97Earnings per share¥0.34
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 17.29x
- Typical range
- 14.69x–20.81x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.14x
015304560
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.14x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
600276SHHengrui Pharma | 35.92x | 18.32% | ¥319.05B |
002422SZKELUN PHARMA | 34.49x | 10.36% | ¥67.88B |
600085SHTRT | 37.16x | 10.72% | ¥32.61B |
600329SHDRTG | 34.09x | 51.62% | ¥30.53B |
600521SHHuahaipharm | 26.64x | 411.11% | ¥25.19B |
002262SZNHWA | 20.89x | 11.43% | ¥22.92B |
000739SZAPELOA | 28.11x | 11.87% | ¥22.60B |
002773SZKHPG | 22.61x | -- | ¥20.67B |
600867SHTHDB | 27.31x | 53.23% | ¥14.88B |
603456SHJiuzhou Pharma | 23.88x | 17.48% | ¥14.31B |
603707SHNKF | 32.18x | 0.00% | ¥13.68B |
600664SHHPGC | 20.56x | 71.43% | ¥13.02B |
300357SZWolwo Pharma | 26.57x | 18.88% | ¥11.36B |
002019SZYifan Pharmaceutical | 34.83x | 3.03% | ¥10.84B |
600420SHSHYNDEC | 23.68x | -- | ¥10.69B |
600572SHCONBA | 22.92x | -- | ¥10.47B |
688076SHSinopep | 39.18x | 91.51% | ¥8.74B |
000756SZXinhua Pharm | 37.13x | -- | ¥8.49B |
002550SZQianhong Bio-pharma | 34.11x | -- | ¥7.87B |
300119SZRINGPU | 22.63x | 2.44% | ¥7.63B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
